Development of an Allogeneic Universally Tolerated NKT Cell Platform for Off-the-Shelf Cancer Immunotherapy

被引：0
|
作者：
Jin, Jingling [1 ]
Liu, Bin [1 ]
Guo, Linjie [1 ]
Di Pierro, Erica J. [1 ]
Balzeau, Julien [1 ]
Courtney, Amy [1 ]
Ngai, Ho [1 ]
Metelitsa, Leonid S. [1 ]
机构：
[1] Baylor Coll Med, Houston, TX 77030 USA
来源：
MOLECULAR THERAPY | 2019年 / 27卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
682
引用
收藏
页码：321 / 321
页数：1
相关论文
共 50 条
  • [1] Development of an Allogeneic Nkt Cell Platform for Off-The-Shelf Cancer Immunotherapy
    Jin, Jingling
    Liu, Bin
    Courtney, Amy N.
    Ngai, Ho
    Metelitsa, Leonid S.
    MOLECULAR THERAPY, 2018, 26 (05) : 173 - 173
  • [2] Allogeneic "Zombie Cell" as Off-The-Shelf Vaccine for Postsurgical Cancer Immunotherapy
    Li, Bo
    Zhang, Ping
    Li, Junlin
    Zhou, Rui
    Zhou, Minglu
    Liu, Chendong
    Liu, Xi
    Chen, Liqiang
    Li, Lian
    ADVANCED SCIENCE, 2024, 11 (13)
  • [3] Development of allogeneic HSC-engineered iNKT cells for off-the-shelf cancer immunotherapy
    Li, Yan-Ruid
    Zhou, Yang
    Kim, Yu Jeong
    Zhu, Yanni
    Ma, Feiyang
    Yu, Jiaji
    Wang, Yu-Chen
    Chen, Xianhui
    Li, Zhe
    Zeng, Samuel
    Wang, Xi
    Lee, Derek
    Ku, Josh
    Tsao, Tasha
    Hardoy, Christian
    Huang, Jie
    Cheng, Donghui
    Montel-Hagen, Amelie
    Seet, Christopher S.
    Crooks, Gay M.
    Larson, Sarah M.
    Sasine, Joshua P.
    Wang, Xiaoyan
    Pellegrini, Matteo
    Ribas, Anton
    Kohn, Donald B.
    Wirtte, Owen
    Wang, Pin
    Yang, Lili
    CELL REPORTS MEDICINE, 2021, 2 (11)
  • [4] Development of Allogeneic HSC-Engineered iNKT Cells for Off-the-Shelf Cancer Immunotherapy
    Yang, Lili
    MOLECULAR THERAPY, 2022, 30 (04) : 512 - 512
  • [5] Development of Allogeneic HSC-Engineered iNKT Cells for Off-the-Shelf Cancer Immunotherapy
    Li, Yanruide
    MOLECULAR THERAPY, 2023, 31 (04) : 742 - 743
  • [6] Development of a personalized off-the-shelf whole-cell immunotherapy for breast cancer
    Sunkari, Vivekananda
    Graeve, Sanne
    Peoples, George E.
    Wiseman, Charles L.
    Williams, William V.
    Lacher, Markus D.
    CANCER RESEARCH, 2019, 79 (13)
  • [7] Off-the-shelf tumor immunotherapy with genetically enhanced allogeneic T cell precursors
    Zakrzewski, Johannes L.
    Suh, David
    Markley, John
    King, Christopher
    Smith, Odette M.
    Goldberg, Gabrielle
    Jenq, Robert
    Holland, Amanda M.
    Lu, Sydney
    Sant'Angelo, Derek
    Riviere, Isabelle
    Sadelain, Michel
    van den Brink, Marcel R. M.
    FASEB JOURNAL, 2008, 22
  • [8] Development of a Novel Allogeneic γδ-T Platform for Off-the-Shelf Adoptive Cell Therapy for Oncology and Autoimmune Diseases
    Nanbakhsh, Arash
    Wlodarek, Lukasz
    Nguyen, Kevin
    Lan, Weijie
    MOLECULAR THERAPY, 2024, 32 (04) : 846 - 847
  • [9] Targeted 'Off-the-Shelf' tumor immunotherapy using allogeneic T-Cell precursors
    Zakrzewski, Johannes L.
    Suh, David
    Smith, Odette M.
    King, Christopher
    Goldberg, Gabrielle L.
    Jenq, Robert
    Holland, Amanda M.
    Grubin, Jeremy
    Lu, Sydney X.
    Cabrera-Perez, Javier
    Rizzuto, Gabrielle
    Sant'Angelo, Derek B.
    van den Brink, Marcel R. M.
    Markley, John C.
    Riviere, Isabelle
    Sadelain, Michel
    Zuniga-Pflucker, Juan Carlos
    BLOOD, 2007, 110 (11) : 178A - 178A
  • [10] Manufacturing Off-the-Shelf Allogeneic NK Cell-Based Immunotherapy via Hydroporator®
    Kim, Hyelee
    Lee, Mujin
    Han, Bohwa
    Kim, Jinho
    Cho, Duck
    Doh, Junsang
    Chung, Aram
    MOLECULAR THERAPY, 2024, 32 (04) : 370 - 371
12345